Poly Medicure Limited has announced a scheduled one-on-one meeting with analysts and investors following regulatory disclosure requirements. The meeting is set for Monday, March 30th, 2026, involving representatives from Front Wave Research LLP. The interaction will be conducted virtually at 03:30 P.M. The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during this engagement.
Disclosure of Analyst Meet Schedule
Poly Medicure Limited officially communicated the schedule for upcoming engagements with market participants, adhering to disclosure guidelines. The company confirmed that its officials will conduct a one-on-one meeting with analysts and investors as detailed below.
Meeting Details Summary
The required details regarding the participants and logistics for the scheduled meeting are as follows:
- Participant: Front Wave Research LLP
- Date and Time: Monday, 30th March, 2026, at 03:30 P.M.
- Venue/Format: The meeting will be held in a Virtual format, categorized as a One-on-one interaction.
Important Caveats
The management noted that this schedule remains subject to change based on any exigencies arising from the side of the Analysts/ Investors or the Company itself. Importantly, Poly Medicure Limited confirmed that no Unpublished Price Sensitive Information (UPSI) will be disclosed during the course of this discussion.
The confirmation for this schedule was received on relatively shorter notice, necessitating this immediate intimation to the exchanges. Further details, including this information, are also made available on the Company’s official website, www.polymedicure.com.
Source: BSE
